A new pool of experts in prostate cancer
Connecting clinicians, academics and industry to accelerate prostate cancer breakthroughs
Through PCR’s translational programme, Proven Connect, an increasing number of companies are seeking to connect to academics in specialist areas of...
News Information
Date: July 31, 2023
Author:
New investment into Nanovery
Thanks to Proven Connects investor partnership with UKRI we were able to be the lead the latest investment round Nanovery
Thanks to Proven Connects investor partnership with UKRI we were able to be the lead the latest investment round Nanovery. Nanovery have successful...
News Information
Date: December 22, 2022
Author: Jayne Spink
“Unlocking the Potential of Prostate Cancer Data”
Download our report recent PCR Report “Unlocking the Potential of Prostate Cancer Data” that highlights the challenges that researchers have in accessing health-related data.
Our report PCR Report “Unlocking the Potential of Prostate Cancer Data” highlights the challenges that researchers have in accessing health-related...
News Information
Date: November 17, 2022
Author: Jayne Spink
ODP2 PART 3: DEVELOP IS NOW CLOSED
Congratulations to the finalists
Proven Connect was delighted to partner with Lean Life Science for a new Oncology programme launching in 2023. Applications for the programme are n...
News Information
Date: April 26, 2023
Author: Jayne Spink
Investor Partner for the UKRI Future Economy investor partnership programme
PCR has been granted investor partner status for the UK governments new aligned funding scheme
Description
Innovate UK, as part of UK Research and Innovation, has selected a pool of investor partners. These investor partners have demonstra...
News Information
Date: August 1, 2023
Author: Jayne Spink
Introducing Proven Connect, a new translational programme for PCR
Prostate Cancer Research has announced a new programme of work that will deliver on the charity’s commitment to support and accelerate translational research. Proven Connect will work to improve access to seed funding, expertise and networks and to build collaborations and partnerships in the translational research space.
Through Proven Connect, PCR will co-invest with venture capital funders and impact investors and connect companies to the resources and expert supp...
News Information
Date: February 28, 2022
Author: Jayne Spink